Data from a cohort with antibodies against the extracellular region of AQP1 in patients with CNS demyelination and NMOSD phenotype showed LETM to be a basic clinical component [55] and in some patients this was also combined with optic neuritis; consequently they had core clinical characteristics of NMOSD. Here, AQP1 is linked to CNS demyelination.